France

The cannabis market: helping investors navigate the UK regulatory regime

Matthew Townsend

Last year the global legal cannabis market was estimated to be worth USD12 billion but it is tipped to rise to over USD166 billion by 2025. Liberalisation of the legal framework for cannabis is a significant driver for this growth. Since 1 November 2018, the UK has joined the ranks of over 30 countries legalising Read More

Medical cannabis in France: Latest state of play

Eveline Van Keymeulen

Following the penultimate meeting of the specialised committee on cannabis (CSST) established by the French National Agency of Medicine and Health Products Safety (ANSM) (see our previous blog posts “French ANSM temporary scientific committee pursues activities on modalities of medical cannabis availability” and¬†“French ANSM recommends medical use of cannabis under certain conditions“), the French Senate Read More

French medicines agency announces action against “short-liner” wholesale distributors

Eveline Van Keymeulen

On 6 May 2019, the French National Agency of Medicine and Health Products Safety (ANSM), facing the challenges of stock shortages and the risks of introducing falsified medicines into circulation, published an announcement on action against “short-liner” wholesale distributors. Wholesale distributors, holding authorisations granted by the ANSM, carry out the purchase, sale, storage and distribution Read More

AI in health: the launch of the French Health Data Hub

Laurie-Anne Ancenys

The French Office parlementaire d’√©valuation des choix scientifiques (the Office) has published a report on artificial intelligence and health data following the public hearing organised in February 2019, in the form of two round tables on artificial intelligence and health data. The hearing, attended by AI researchers, entrepreneurs, public and private stakeholders of the health Read More

French ANSM temporary scientific committee pursues activities on modalities of medical cannabis availability

Eveline Van Keymeulen

On 15 May 2019, the French Temporary Specialised Scientific Committee (CSST) met to continue its work on the modalities of making cannabis for therapeutic purposes available during the initial experimental phase. The CSST was created in September 2018 for one year by the French National Agency of Medicine and Health Products Safety (ANSM) to assess Read More